Brief: MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
Sept 22 (Reuters) - MindWalk Holdings Corp HYFT.O: MINDWALK ADVANCES AI-DESIGNED GLP-1 PROGRAM WITH FIRST-IN-CLASS DUAL-PATHWAY REGIMEN FOR AGING AND LONGEVITY Source text: ID:nBw8xLxhQa Further company coverage: HYFT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai